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Abstract
Background: Of the nearly 100,000 street-based IDUs in Pakistan, 20% have HIV. We investigated
the recent rise in HIV prevalence from 12 to 52% among IDUs in Sargodha despite > 70% coverage
with syringe exchanges.
Methods: We interviewed approximately 150 IDUs and 30 outreach workers in focus group
discussions.
Results: We found six rural and 28 urban injecting locations. Urban locations have about 20–30
people at any time and about 100 daily; rural locations have twice as many (national average: 4–15).
About half of the IDUs started injecting within the past 2 years and are not proficient at injecting
themselves. They use street injectors, who have 15–16 clients daily. Heroin is almost exclusively
the drug used. Most inject 5–7 times daily.
Nearly all injectors claim to use fresh syringes. However, they load, inject and share using a locally
developed method called scale. Most Pakistani IDUs prefer to double pump drug the syringe, which
allows mixing of blood with drug in the syringe. The injector injects 3 ml and keeps 2 ml (the scale)
as injection fee. The injector usually pools all the leftover scale (now with some blood mixed with
drug) either for his own use or to sell it. Most IDUs backload the scale they buy into their own
fresh syringes.
Discussion:  Use of an unprecedented method of injecting drugs that largely bypasses fresh
syringes, larger size of sharing networks, higher injection frequency and near universal use of street
injectors likely explain for the rapid rise in HIV prevalence among IDUs in Sargodha despite high
level provision of fresh syringes. This had been missed by us and the national surveillance, which is
quantitative. We have addressed this by hiring injectors as peer outreach workers and increasing
syringe supply. Our findings highlight both the importance of qualitative research and operations
research to enrich the quality of HIV prevention programs.
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Background
Ever since an outbreak heralded its onset in 2003 [1-3],
the HIV epidemic has expanded explosively among Paki-
stan's injection drug users (IDUs). The National AIDS
Control Program (2006) estimates that there are an esti-
mated 146,000 IDUs in Pakistan[4] of which about
80,000 to 100,000 are street-based. By 2007, nearly 20%
of these street-based IDUs nationwide were infected with
HIV[5]. Most inject about 2–3 times a day and in groups
of 4–10. Specific drugs used vary by city and include opi-
oids (e.g. heroin, buprenorphine), benzodiazepines (e.g.
diazepam), solvents (e.g. rubber glue), antihistamines
(e.g. Phenirimine) etc[5-8]. Overall the experience in
Pakistan has been consistent with that from other Asian
countries where HIV epidemics were started among IDUs
as well[9,10].
The mainstay of HIV prevention for IDUs is syringe-nee-
dle exchange [11-16]. Behavior change counseling,
detoxification, rehabilitation, social and medical services,
antiretroviral therapy and oral substitution therapy also
play a vital role [17-22]. All these interventions are avail-
able in Pakistan except oral substitution therapy. They are
offered as part of citywide projects that are funded by the
government and implemented by non-governmental
organizations. Nai Zindagi (New Life) is one such organi-
zation that implements HIV interventions for about
12,000 IDUs in four cities including Sargodha. The inter-
ventions provided include syringe-needle exchange, vol-
untary counseling and testing (VCT) for HIV, wound and
healthcare, counseling, detoxification and rehabilitation.
In December 2006, the national surveillance showed that
HIV prevalence in Sargodha had reached 51.3%[5]; up
from 12% in a survey from July 2005[8]. These latter
results were consistent with Nai Zindagi's VCT data. The
same survey also showed that there were about 2450
street-based IDUs in Sargodha, who were a median of 30
years old and had injected for about 3 years. Over 70%
live at home with family or relatives. Most (75%) report
using street injectors some or most of the time and 38%
had done so with their last injection. They injected a
median of 3 times a day and over 80% reported injecting
their last dose in a group. Heroin was the principal drug
used. However, 90% reported using a new syringe with
their last injection and of the remaining, 88% reported
cleaning their syringes (usually with water)[5]. In the 18
months prior to December 2006, the NGO had registered
1450 clients and supplied 390,000 syringes (but not any
other injecting paraphernalia). There are no other services
available for IDUs in the city.
Experience from Vancouver, B.C., Canada has shown that
mere syringe distribution is insufficient for curtailing HIV
transmission. While many factors limited the efficacy of
the program (users transitioning to cocaine, more fre-
quent users availing the services etc), a key problem seen
in Vancouver was that the injecting behaviors of IDUs
changed insufficiently despite the availability of new
syringes[23]. This was not the case in Sargodha where
nearly all IDUs reported either using new syringes for
injections or cleaning their old syringes before use. We
conducted this assessment to understand why HIV had
spread so explosively among IDUs in Sargodha, despite a
consistent supply of new syringes to approximately 70–
80% of all street-based IDUs in Sargodha, who were also
demonstrating very little sharing on independent assess-
ments.
Methods
We interviewed approximately 150 IDUs in 4 focus group
discussions and 30 outreach workers in one focus group
discussion, in July 2007. Although their specific demo-
graphic data were not collected for this assessment, IDUs
in Sargodha are a median of 30 years old with a range
from 15 to 70 years. All participants were males and eth-
nic Punjabis. Since outreach workers are hired from IDUs,
they have similar demographic characteristics. We con-
ducted one discussion with IDUs in a rural location and
two at urban locations, while the drop in center discus-
sion had both urban and rural participants. These sites
were selected randomly. IDUs were recruited on the basis
of their presence at the injection sites when the study team
arrived. All IDUs present at the site at the time were
allowed to participate on a voluntary basis. None were
excluded if they wanted to participate. During the discus-
sion, IDUs moved in and out of discussions freely. The
discussion with out-reach workers was conducted after the
IDU discussions in order to verify findings and to add
detail. All outreach workers working for the NGO in the
city were specially asked to attend this discussion.
The discussions were guided by a pre-designed question-
naire that were pre-tested with a smaller group of IDUs at
the local drop in center. The questionnaires asked about
the type and frequency of drugs used, injecting practices,
sharing behaviors and sexual practices. The discussants
were encouraged to add details beyond specific questions,
including topics that they felt were pertinent but had not
been included in the questionnaire. The discussions were
led by ABA who was assisted by AAK. The study team took
notes of salient points but did not transcribe or record the
discussions. The points were repeated back to the group
during and at the end of the discussion to assure their
agreement with the notes and to solicit further comments.
No software or coding scheme were applied to data. Dis-
cussions were continued until saturation was reached for
the themes that were emerging. The study team met at the
end of each discussion to go over the answers received and
to assure that our questions were sufficient to address anyHarm Reduction Journal 2009, 6:13 http://www.harmreductionjournal.com/content/6/1/13
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emerging themes. It was decided that pertinent emerging
themes were reasonably covered by our questionnaire and
by allowing participants to elaborate freely on the themes
observed.
Routine assessments to inform about aspects of delivery
of services are integral to our project design. These are con-
ducted monthly by our city level team and quarterly or
biannually by the national team. These frequently involve
discussions with IDUs and outreach workers, and allows
them to influence the services they receive or provide. As
no personal information is sought or an individual iden-
tified, additional ethical review is not sought. The same
principle applied to this assessment. Since the drug user
interviews/discussions were held in open public spaces
participants freely moved in and out of the group and
were not coerced into answering our queries.
No compensation was provided to participants. The NGO
routinely inquires about aspects of delivery of services
from its clients. These services are considered sufficient
compensation for our clients to for the time they spend
with our staff. Finally, since this rapid assessment
explored the reasons for rise in prevalence that appeared
consistent across data sources (national surveillance and
our own VCT), no additional biological tests were per-
formed.
Results
IDUs that participated in our discussions were all men,
aged 15 to 70 years and ethnic Punjabis. Outreach work-
ers are all former IDUs and therefore have a similar demo-
graphic profile. Some IDUs are small farmers or day-
laborers, however, most IDUs claimed their income is
from begging, odd jobs or garbage collection. We found a
few affluent businessmen in the drop-in center group.
Outreach workers describe considerable contribution
from theft. Only 294 of our currently registered 1400 cli-
ents sleep on the street at night, the remaining return to
their homes. Few (an estimated 5–6%) felt they were sex-
ually active. We saw only one woman IDU (who was
under the influence and did not participate in the discus-
sion) at any of the locations. Women IDUs are uncom-
mon on the street as described by other IDUs and peer
workers. Most IDUs were local residents.
Six rural and 28 urban injecting locations (called "spots"
locally) were identified in Sargodha. A typical urban loca-
tion is situated in a large vacant lot in a residential neigh-
borhood and has about 20–30 IDUs at any given time and
about 100 daily. Rural locations are located in clearings in
the middle of farms and can have about 30–40 IDUs at a
time and about 100–200 daily. Shooting galleries have
not been observed in Sargodha. Within each location,
IDUs inject in subgroups that retain about the same mem-
bers for days or weeks to some extent. While specific loca-
tion of spots within neighborhoods change due to police
raids or community pressure, the overall neighborhoods
where injecting occurs remain the same over the years, i.e.
when relocating, spots tend to stay in the same neighbor-
hoods in the city. This is truer for urban locations than for
rural ones. Injecting activities continue during all daylight
hours at all spots.
Many IDUs move between spots on any given day, mostly
to adjacent or nearby spots. Most return to their own spot
either the same or the next day. Approximate motility of
an IDU is about 1–2 spots per week. Longer-term mobility
either between spots or to other cities is less common and
is usually motivated by family relocations and infre-
quently due to drugs availability.
Some IDUs inject and smoke heroin on the same day. The
commonest reasons for switching to injecting are finan-
cial. Injected drugs give a greater "high" and therefore are
economical (most IDUs claim that it takes 2–3 times
higher amounts of smoked heroin to produce the same
level of "high"). Injecting drugs is relatively new for Sar-
godha and started around 10–12 years ago but has taken
off in the recent years. We found that with the exception
of a few IDUs that had injected for more than 10 years,
most IDUs had started injecting within the past 2 years
and nearly all for less than 5 years. Consequently, most
were not yet proficient in injecting themselves and turned
to street injectors (called "street doctors"). These are more
experienced IDUs that inject others for a fee. Typically
there were 2–3 injectors present at a spot of 30 IDUs and
each injected about 15–16 persons daily.
Heroin is almost exclusively the drug used in Sargodha. It
is available in single dose sachets (locally called a
"token"). Most claim to inject 5–7 times a day. It is nearly
always dissolved in Phenirimine (Avil®, an antihistamine)
which is felt to augment the "high" of heroin. The most
frequently used form of Phenirimine is a veterinary for-
mulation, which is sold in multi-user vials that look like
they had been refilled at home. Less of often (at one spot
where Phenirimine was unavailable) lemon juice is used
to dissolve heroin.
An injection costs about Rs 60–70 (USD 1–1.15) of which
the drug is about Rs 40, the syringe: Rs 5, Phenirimine: Rs
5, and injection fee: Rs 10–20. Usually the group or the
street injector will procure the Phenirimine multi-user vial
(stated price: Rs 38, usual street value: Rs 10–20) which
yields about 10 injections. The drugs and paraphernalia
are paid for in cash, syringes or a share of the dissolved
drug called "scale" (described below).
Nearly all IDUs claim to use fresh syringes all the time.
However since they receive only 2 syringes a day, many
reuse their own syringes. Some sell used syringes to othersHarm Reduction Journal 2009, 6:13 http://www.harmreductionjournal.com/content/6/1/13
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and to local pharmacies. Used syringes cost about the
same as new ones.
Syringes are loaded, injected and shared by a locally devel-
oped method called "scale". The IDU procures and brings
heroin powder to the injector who then dissolves it in
Phenirimine making up a 5 ml mixture. This mixing can
happen by either "back-loading" drug powder in the
syringe (the plunger is removed, the drug powder is
placed in the syringe and the plunger is replaced) and
drawing up 5 ml of Phenirimine directly from the vial; or
the dried drug powder and the Phenirimine are mixed
together in a separate container, and then drawn up into
the syringe. During drug injection, most Pakistani IDUs
prefer to double pump the syringe, where the plunger is
pushed half way through and then retracted (pulling back
some blood) and then rapidly pushed to the desired
amount. The injector typically injects 3 ml and keeps 2 ml
for himself, which he will aliquot into his own new or old
syringe. The injector's portion is called "scale". The injec-
tor usually pools all the leftover "scale" either for his own
use or to sell it. "Scale" is worth slightly less than the reg-
ular drug as IDUs feel it is not as strong as the regular drug.
Discussion
Use of an unprecedented method of injecting drugs that
bypasses fresh syringes, larger sharing networks, higher
injection frequency and common use of street injectors
seem to explain the rapid rise in HIV prevalence among
IDUs in Sargodha despite high level of provision of fresh
syringes.
The method of sharing syringes called "scale" appears the
main reason for the rapid rise in HIV in Sargodha. This
process is multi-factorial. IDUs in Sargodha are poorer
than those in other cities and start injecting about 2 years
into their drug use rather than the 6–7 years it takes in
other cities[6-8,24]. This time may be too short for many
users to learn to inject themselves and many rely on street
injectors. Fairbairn et al have described higher HIV risk
associated with street injectors[25]. Poverty also limits the
ability to pay for the drugs, paraphernalia and services;
which are then paid for by sharing the drug by a method
called "scale". The shared drug is mixed with blood due to
the double pumping that appears to be common among
Pakistani IDUs. This sharing method essentially bypasses
fresh syringes as the drug-blood is passed on and injected
with new syringes, in effect causing a near universal shar-
ing of drug-blood mixture between IDUs, even when a
new syringe is used. Since the "scaled" drug mixture is
sold to be injected as is (or back-loaded into the IDU's
own fresh syringe), an important protection – that of
cleaning used syringes[26,27] – is also bypassed. Mixing
of drugs prior to being aliquoted for multiple IDUs has
been described previously from Hungary[28] and Russia
(Arkadiuz Majszyk, personal communication). However,
the double pumping of syringe with consequent mixing of
blood with drug renders the Sargodha experience riskier.
Finally, this practice is novel and was completely unfore-
seen by us and missed by the national surveillance which
is quantitative. Our findings highlight the significance of
qualitative assessments as routine parts of program evalu-
ations.
Sargodha is on one of the main heroin trafficking routes
from Afghanistan. Drug traffickers "off-load" some drug
in Sargodha. Off-loading is the phenomenon where a cer-
tain amount of drug is sold off cheaply in local markets in
order to meet local expenses. This partly explains why her-
oin found in Sargodha is relatively pure and cheaper. Her-
oin requires more frequent injections[29], in part due to
its short half life of 9–22 minutes[30]. While IDUs from
other cities use cocktails of synthetic opioids and benzo-
diazepines, and inject 2–3 times daily (national average:
2.7)[7,8], IDUs from Sargodha use heroin exclusively[8]
and may inject 6–7 times daily, enhancing their potential
exposure to blood from HIV-infected compatriots.
Size and density of sharing networks are key determinants
of sexual transmission of HIV and STIs [31-35]. A similar
dynamic may operate for syringe sharing networks, partic-
ular when large groups of IDUs sit together and inject,
although this remains unproven. The syringe sharing net-
works in Sargodha are 2–3 folds larger than in most other
Pakistani cities, due to unclear reasons. These larger net-
works may have contributed to the rapid rise in HIV prev-
alence. Our observations warrant more detailed study of
how these networks form and operate and why they are
larger in Sargodha than elsewhere.
There are several limitations of this assessment. This is a
brief assessment of situation and did not use a scientifi-
cally rigorous sampling frame. However, we discussed
with nearly 200 current or recent former IDUs in a city
with about 2500 IDUs. Even if the sampling frame was
not fully representative, our study sampled the concerns
of a large proportion of the IDUs in the city. Secondly, this
is the first study in Pakistan that suggests that large groups
and networks of IDUs may play a role in rapid transmis-
sion of HIV among IDUs in the country. However, we did
not study the network structure of the injecting commu-
nity. Our recruitment process may have selected for IDUs
that were staying at the injecting sites after their injections
and were therefore more "hardcore" IDUs. IDUs that had
just arrived at the site seeking drug were more likely to
have been in withdrawal and those that had just received
their injection were more likely to be in stupor. Both were
less likely to participate in our discussions. This may have
accounted for the higher injection frequency than was
reported by the national surveillance which took a moreHarm Reduction Journal 2009, 6:13 http://www.harmreductionjournal.com/content/6/1/13
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probability sample of all IDUs. Finally we focused only
mainly on injecting rather than sexual behaviors, since
very few IDUs claimed to be sexually active. In the
national surveillance, 46% of IDUs had reported some
sexual activity in the past 6 months[5], however in
another study (Ahmad et al, under review), this amounted
to about one sex act per month. Sex between IDUs is also
not well studied in Pakistan and may have been important
in the rapid HIV transmission that was observed in the
city.
Several interventions are necessary to reduce HIV trans-
mission in Sargodha. We have already increased the sup-
ply of syringes to match the injecting frequency in
Sargodha and have started supplying single user vials of
Phenirimine and mixing utensils. We are now designing
behavior change interventions for street injectors and will
hire them as peer workers or will pay them to not mix or
sell "scale".
Our study was a quick assessment to understand the
explosive rise in HIV in one city. We found an unprece-
dented method of sharing syringes, more frequent injec-
tions and large sharing networks of IDUs. Such variations
in patterns from other cities underscore the importance of
understanding and using local context to guide harm
reduction programs. We also highlighted the importance
of ongoing research to inform program implementation.
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